Considering the inhibitory effect of low serum leptin levels on the sympathetic system associated with its impairment that occurs during the evolution of neuropathy itself, these patients present an even more favorable scenario for the development of the most severe types of CAN. The gene discussed is LEP; the disease is neuropathy.